KMT5A and breast carcinoma: The variant allele C may decrease the expression of SET8 through enhancing the binding capacity of miR-502 to target site in the 3′UTR of SET8. The CC genotype was associated with reduced SET8 protein expression, which was consistent with previous studies in breast cancer had hepatocellular carcinoma [35], [37].